Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sutro Biopharma, Inc. - Common Stock
(NQ:
STRO
)
0.5953
-0.0553 (-8.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sutro Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Where Sutro Biopharma Stands With Analysts
October 23, 2023
Via
Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
October 06, 2023
Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
5 Analysts Have This to Say About Sutro Biopharma
October 06, 2023
Via
Benzinga
Where Sutro Biopharma Stands With Analysts
August 11, 2023
Via
Benzinga
6 Analysts Have This to Say About Sutro Biopharma
June 12, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
April 03, 2023
Via
Benzinga
Where Sutro Biopharma Stands With Analysts
March 31, 2023
Via
Benzinga
Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate
January 10, 2023
Via
Benzinga
Recap: Sutro Biopharma Q2 Earnings
August 08, 2022
Sutro Biopharma (NASDAQ:STRO) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Short Volatility Alert: Sutro Biopharma, Inc.
June 29, 2022
On Tuesday, shares of Sutro Biopharma, Inc. (NASDAQ: STRO) experienced volatile short activity. After the activity, the stock price went up +20.79% to $5.23. The overall sentiment...
Via
Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
June 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
Via
Benzinga
Why Investors Are Suddenly Excited About Vaxcyte
October 31, 2022
Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.
Via
MarketBeat
Exposures
COVID-19
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
October 25, 2022
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
Via
Benzinga
Avis Budget, Scholastic And Other Big Gainers From Monday
October 25, 2022
U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
September 01, 2022
According to data from Benzinga Pro, during Q2, Sutro Biopharma's (NASDAQ:STRO) reported sales totaled $28.10 million. Despite a 33.49% increase in earnings, the company posted a loss of $26.01...
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
June 28, 2022
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
June 29, 2022
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
Markets Open Higher; US Goods Gap Narrows To $104.3B In May
June 28, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday.
Via
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 28, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning!
Via
InvestorPlace
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
June 28, 2022
Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
During the Thursday's session, 100 stocks hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.